| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/06/2002 | WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
| 06/06/2002 | WO2001094333A3 Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives |
| 06/06/2002 | WO2001094293A3 Benzamide ligands for the thyroid receptor |
| 06/06/2002 | WO2001093841A3 Barbituric acid analogs as therapeutic agents |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | WO2001068071A3 Use of natural chrysanthone compounds having antiangiogenic activity |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001003684A3 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/06/2002 | US20020068831 Intermediate for the synthesis of amlodipine, a process for the preparation there and corresponding use |
| 06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068753 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
| 06/06/2002 | US20020068739 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 06/06/2002 | US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc. |
| 06/06/2002 | US20020068731 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/06/2002 | US20020068729 Quaternary salts of substituted imidazoles, oxazoles and thiazoles |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/06/2002 | US20020068719 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068700 Treatment of heart failure with growth hormone |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068692 Administration a melatonin blocker to patients with disorders associated with altered dopamine function; preclinical diagnosis by administering melatonin to induce a mild transient form of the disorder |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068102 Use of dietary supplement includes juice from fruit of Morinda citrifolia to scavange lipid hydroperoxides and superoxide anion free radicals within the human body |
| 06/06/2002 | US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 06/06/2002 | US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers |
| 06/06/2002 | DE10060470A1 Thermoplastische und wasserlösliche Celluloseether-ester Thermoplastic and water-soluble cellulose ether-ester |
| 06/06/2002 | DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 06/06/2002 | DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction |
| 06/06/2002 | CA2689915A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2625277A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2430924A1 Angiotensin receptor antagonist composition for the treatment of sexual dysfunction associated with hypertension and another condition |
| 06/06/2002 | CA2430409A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430309A1 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430133A1 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | CA2430061A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | CA2429801A1 Behavior chemotherapy |
| 06/06/2002 | CA2429615A1 Determination of risk and treatment of complications of prematurity |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2428552A1 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2002 | CA2427681A1 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 06/06/2002 | CA2427618A1 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | CA2425892A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivative or salt thereof |
| 06/06/2002 | CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
| 06/05/2002 | EP1211253A1 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 06/05/2002 | EP1211249A1 Novel thiazine or pyrazine derivatives |
| 06/05/2002 | EP1211247A1 Acylamino cyclopropane derivatives |
| 06/05/2002 | EP1211242A1 Prostaglandin derivatives |
| 06/05/2002 | EP1211241A1 Prostaglandin e analogues |
| 06/05/2002 | EP1210951A2 Combination for treating andropause containing estrogen agonists/antagonists and testosterone |
| 06/05/2002 | EP1210945A1 Pharmaceutical composition with antiarteriosclerotic activity |
| 06/05/2002 | EP1210874A1 Alpha-tocopherol transport protein knockout animal |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210453A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 06/05/2002 | EP1210439A1 Coxsackie virus-derived vector system for gene transfer |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210425A2 Baff receptor (bcma), an immunoregulatory agent |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210405A2 Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210350A1 Water soluble sdz-rad esters |
| 06/05/2002 | EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES |
| 06/05/2002 | EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 06/05/2002 | EP1210345A1 Oxazole ppar antagonists |
| 06/05/2002 | EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210117A2 Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210099A1 Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras |
| 06/05/2002 | EP1210087A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| 06/05/2002 | EP1210085A2 Pharmaceutical solutions of levosimendan |
| 06/05/2002 | EP1210083A2 Methods for the treatment of mental and vascular disorders |